Known targets — ChEMBL curated mechanism
rplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Calcium Gluceptate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.87 |
| ▸ | PDE4A | P27815 | 1/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.48 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | CA4 | P22748 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Calcium Gluceptate SCHEMBL29361230 | 1.00 | LMNA (0.87) | LMNAPDE4ATDP1L3MBTL1USP2 | |
| Calcium Gluceptate SCHEMBL29877402 | 1.00 | LMNA (0.87) | LMNAPDE4ATDP1L3MBTL1USP2 | |
| Calcium Gluceptate SCHEMBL517446 | 1.00 | LMNA (0.87) | LMNAPDE4ATDP1L3MBTL1USP2 | |
| Calcium Gluceptate SCHEMBL517447 | 1.00 | LMNA (0.87) | LMNAPDE4ATDP1L3MBTL1USP2 | |
| SCHEMBL6907170 | 1.00 | LMNA (0.87) | LMNAPDE4ATDP1L3MBTL1USP2 | |
| SCHEMBL28073209 | 0.98 | LMNA (0.83) | LMNAPDE4ATDP1L3MBTL1USP2 | |
| Water SCHEMBL29706462 | 0.98 | LMNA (0.83) | LMNAPDE4ATDP1L3MBTL1USP2 | |
| Gluconic Acid SCHEMBL23415272 | 0.98 | LMNA (0.91) | LMNAPDE4ATDP1L3MBTL1USP2 | |
| Gluconic Acid SCHEMBL24132 | 0.98 | LMNA (0.91) | LMNAPDE4ATDP1L3MBTL1USP2 | |
| Gluconic Acid SCHEMBL16180766 | 0.98 | LMNA (0.91) | LMNAPDE4ATDP1L3MBTL1USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 916 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4537831-A2 | PHARMACEUTICAL COMPOSITIONS WITH ANTI-RANKL ANTIBODIES, CALCIUM AND VITAMIN D, SUITABLE FOR THE TREATMENT AND/OR PROPHYLAXIS OF DISORDERS OF THE BONE METABOLISM AND THERAPY-INDUCED SIDE EFFECTS SUCH AS HYPOCALCEMIA | Karl, Christoph (CH) | 2025-04-16 | — | — | EP | claimed |
| EP-4501330-A2 | PHARMACEUTICAL COMPOSITIONS WITH ANTI-RANKL ANTIBODIES, CALCIUM AND VITAMIN D, SUITABLE FOR THE TREATMENT AND/OR PROPHYLAXIS OF DISORDERS OF THE BONE METABOLISM AND THERAPY-INDUCED SIDE EFFECTS SUCH AS HYPOCALCEMIA | Karl, Christoph (CH) | 2025-02-05 | — | — | EP | claimed |
| US-20240398819-A1 | UTILITY OF VITAMIN D, FOLIC ACID AND NADH TO IMPROVE LIGAMENT INJURY PREVENTION CHARACTERISTICS | RHODE ISLAND HOSPITAL | 2024-12-05 | — | — | US | claimed |
| CN-113164522-B | Method for preparing platelet release material | 红十字会佛兰德斯研究和发展基金 | 2024-08-27 | — | — | CN | claimed |
| CN-107250318-B | Super concentrate additive solution compositions | 布拉斯通产品公司 | 2023-10-27 | — | — | CN | claimed |
| US-20230218754-A1 | PHARMACEUTICAL COMPOSITIONS WITH ANTI-RANKL ANTIBODIES, CALCIUM AND VITAMIN D | Karl, Christoph (CH) | 2023-07-13 | — | — | US | claimed |
| EP-3739017-B1 | METHOD OF PREVENTING CORROSION OF HEAT TRANSFER SYSTEM | PRESTONE PRODUCTS CORP (US) | 2023-06-07 | — | — | EP | claimed |
| CN-114681605-A | Thermostable hand-foot-mouth vaccine soluble microneedle patch and preparation method thereof | 辽宁成大生物股份有限公司 | 2022-07-01 | — | — | CN | claimed |
| CN-109476541-B | Hardening acceleration/hardening retardation composition for building materials | 洛桑联邦理工学院 | 2022-04-19 | — | — | CN | claimed |
| US-20220096562-A1 | OSTEOBLAST CELL-MIXTURE, AND IMPLEMENTATIONS THEREOF | REGROW BIOSCIENCES PRIVATE LIMITED (IN) | 2022-03-31 | — | — | US | claimed |
| CN-1160997-A | Therapeutic vitamin-calcium combination in unitary Galenic tablet form, method for preparing same and use thereof | INNOTHERA LAB SA (FR) | 1997-10-01 | — | — | CN | claimed |
| EP-0741679-A1 | STORABLE LIQUID CEMENTITIOUS SLURRIES FOR CEMENTING OIL AND GAS WELLS | BJ SERVICES COMPANY (US) | 1996-11-13 | — | — | EP | claimed |
| US-5547506-A | HYDRAULICALLY-ACTIVE CEMENTITIOUS MATERIAL, SET RETARDER, SUSPENSION AGENT, ACTIVATING AGENT, AND WATER | BJ SERVICES COMPANY (US) | 1996-08-20 | — | — | US | claimed |
| WO-1995019942-A1 | STORABLE LIQUID CEMENTITIOUS SLURRIES FOR CEMENTING OIL AND GAS WELLS | BJ SERVICES COMPANY (US) | 1995-07-27 | — | — | WO | claimed |
| US-5380537-A | During surgery. aminocarboxylic acid, calcium salt of complex sugar, lactic acid, salt | ANDERMANN GUY (FR) | 1995-01-10 | — | — | US | claimed |
| EP-0435797-B1 | Ophthalmic irrigation solution used in medicine for the endothelial protection and corneal preservation | ANBEN (FR) | 1994-10-12 | — | — | EP | claimed |
| US-4300569-A | Red blood cell labelling kit | MERCK & CO., INC. (US) | 1981-11-17 | — | — | US | claimed |
| EP-0000253-B1 | DIAGNOSTIC KIT FOR BLOOD POOL IMAGING | MERCK SHARP & DOHME (I.A.) CORP. (US) | 1981-10-28 | — | — | EP | claimed |
| US-4210455-A | USED IN CEMENTING OIL-WELLS | THE DOW CHEMICAL COMPANY (US) | 1980-07-01 | — | — | US | claimed |
| EP-0000253-A1 | Diagnostic kit for blood pool imaging | MERCK SHARP & DOHME (I.A.) CORP. (US) | 1979-01-10 | — | — | EP | claimed |